Mauna Kea Technologies SAS (ALMKT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Mauna Kea Technologies SAS (ALMKT) has a cash flow conversion efficiency ratio of 0.077x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.28 Million ≈ $-2.67 Million USD) by net assets (€-29.42 Million ≈ $-34.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Mauna Kea Technologies SAS - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Mauna Kea Technologies SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Mauna Kea Technologies SAS for a breakdown of total debt and financial obligations.
Mauna Kea Technologies SAS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mauna Kea Technologies SAS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kincora Copper Ltd
AU:KCC
|
-0.005x |
|
ContextVision AB
OL:CONTX
|
-0.022x |
|
Chien Wei Precise Technology Co Ltd
TWO:8092
|
0.096x |
|
EMB Mission Bound AB (publ)
ST:NAVIGO-STAM
|
0.033x |
|
C-Com Satellite Systems Inc.
V:CMI
|
0.006x |
|
Okong Corporation
KQ:045060
|
0.044x |
|
TOUAX
PA:ALTOU
|
-0.167x |
|
Desoto Resources Ltd
AU:DES
|
-0.155x |
Annual Cash Flow Conversion Efficiency for Mauna Kea Technologies SAS (2010–2024)
The table below shows the annual cash flow conversion efficiency of Mauna Kea Technologies SAS from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see Mauna Kea Technologies SAS (ALMKT) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €-24.39 Million ≈ $-28.51 Million |
€-6.32 Million ≈ $-7.39 Million |
0.259x | +494.90% |
| 2023-12-31 | €-17.28 Million ≈ $-20.20 Million |
€-753.00K ≈ $-880.34K |
0.044x | -90.16% |
| 2022-12-31 | €-19.93 Million ≈ $-23.29 Million |
€-8.83 Million ≈ $-10.32 Million |
0.443x | -55.43% |
| 2021-12-31 | €-10.33 Million ≈ $-12.08 Million |
€-10.27 Million ≈ $-12.01 Million |
0.994x | +50.29% |
| 2020-12-31 | €-12.08 Million ≈ $-14.12 Million |
€-7.99 Million ≈ $-9.34 Million |
0.662x | +101.63% |
| 2019-12-31 | €253.00K ≈ $295.78K |
€-10.27 Million ≈ $-12.01 Million |
-40.601x | -2872.05% |
| 2018-12-31 | €7.98 Million ≈ $9.33 Million |
€-10.90 Million ≈ $-12.74 Million |
-1.366x | -134.80% |
| 2017-12-31 | €16.74 Million ≈ $19.58 Million |
€-9.74 Million ≈ $-11.39 Million |
-0.582x | +17.16% |
| 2016-12-31 | €11.16 Million ≈ $13.04 Million |
€-7.84 Million ≈ $-9.16 Million |
-0.702x | +15.62% |
| 2015-12-31 | €14.09 Million ≈ $16.47 Million |
€-11.73 Million ≈ $-13.71 Million |
-0.832x | -18.67% |
| 2014-12-31 | €18.15 Million ≈ $21.22 Million |
€-12.73 Million ≈ $-14.88 Million |
-0.701x | -120.08% |
| 2013-12-31 | €30.16 Million ≈ $35.26 Million |
€-9.61 Million ≈ $-11.24 Million |
-0.319x | +3.61% |
| 2012-12-31 | €40.16 Million ≈ $46.95 Million |
€-13.28 Million ≈ $-15.53 Million |
-0.331x | -176.02% |
| 2011-12-31 | €51.57 Million ≈ $60.30 Million |
€-6.18 Million ≈ $-7.22 Million |
-0.120x | +67.12% |
| 2010-12-31 | €6.86 Million ≈ $8.02 Million |
€-2.50 Million ≈ $-2.92 Million |
-0.364x | -- |
About Mauna Kea Technologies SAS
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate… Read more